Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 15172-15173 [E7-5918]

Download as PDF 15172 Federal Register / Vol. 72, No. 61 / Friday, March 30, 2007 / Notices Register and served on the parties to the hearing. NUCLEAR REGULATORY COMMISSION III. Opportunity To Provide Written Comments [Docket Nos. 50–361 and 50–362] In accordance with 10 CFR 2.1305, as an alternative to requests for hearing and petitions to intervene, comments with respect to this action should be provided in writing by April 30, 2007. The Commission will consider and, if appropriate, respond to these comments, but such comments will not otherwise constitute part of the decisional record. Comments should be submitted to the Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, Attention: Rulemakings and Adjudications Staff, and should cite the publication date and page number of this Federal Register notice. IV. Further Information For further details with respect to this action, see the application dated January 19, 2007, and supplements dated; February 23, 2007, and March 2, 2007, available for public inspection at the Commission’s Public Document Room (PDR), located at One White Flint North, Public File Area O1 F21, 11555 Rockville Pike (first floor), Rockville, Maryland. Publicly available records will be accessible electronically from the Agencywide Documents Access and Management System’s (ADAMS) Public Electronic Reading Room on the Internet at the NRC Web site, http:// www.nrc.gov/reading-rm/adams.html. Persons who do not have access to ADAMS, or who encounter problems in accessing the documents located in ADAMS should contact the NRC PDR Reference staff by telephone at 1–800– 397–4209, or 301–415–4737, or via email to pdr@nrc.gov. Dated at Rockville, Maryland this 23rd day of March 2007. For the Nuclear Regulatory Commission. Gary S. Janosko, Deputy Director, Fuel Facility Licensing Directorate, Division of Fuel Cycle Safety and Safeguards, Office of Nuclear Material Safety and Safeguards. [FR Doc. E7–5937 Filed 3–29–07; 8:45 am] cprice-sewell on PROD1PC66 with NOTICES BILLING CODE 7590–01–P Southern California Edison Company, San Diego Gas and Electric Company, the City of Riverside, CA, Notice of Withdrawal of Application for Amendment to Facility Operating License The U.S. Nuclear Regulatory Commission (the Commission) has granted the request of Southern California Edison (the licensee) to withdraw its February 28, 2006, application for proposed amendment to Facility Operating License Nos. NPF–10 and NPF–15 for the San Onofre Nuclear Generating Station, Units 2 and 3, located in San Diego County, California. The proposed amendment would have revised Technical Specifications (TSs) 3.8.1, ‘‘AC [alternating current] Sources—Operating,’’ 3.8.4, ‘‘DC [direct current] Sources—Operating,’’ 3.8.5, ‘‘DC Sources—Shutdown,’’ 3.8.6, ‘‘Battery Cell Parameters,’’ 3.8.7, ‘‘Inverters—Operating,’’ and 3.8.9, ‘‘Distribution Systems—Operating.’’ This change would have also added a new Battery Monitoring and Maintenance Program, Section 5.5.2.16. The Commission had previously issued a Notice of Consideration of Issuance of Amendment published in the Federal Register on July 5, 2006 (71 FR 38185). However, by letter dated March 15, 2007, the licensee withdrew the proposed change. For further details with respect to this action, see the application for amendment dated February 28, 2006, and the licensee’s letter dated March 15, 2007, which withdrew the application for license amendment. Documents may be examined, and/or copied for a fee, at the NRC’s Public Document Room (PDR), located at One White Flint North, Public File Area O1 F21, 11555 Rockville Pike (first floor), Rockville, Maryland. Publicly available records will be accessible electronically from the Agencywide Documents Access and Management Systems (ADAMS) Public Electronic Reading Room on the Internet at the NRC Web site, http:// www.nrc.gov/reading-rm.html. Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in ADAMS should contact the NRC PDR Reference staff by telephone at 1–800–397–4209, or 301–415–4737 or by e-mail to pdr@nrc.gov. Dated at Rockville, Maryland, this 23rd day of March 2007. VerDate Aug<31>2005 15:49 Mar 29, 2007 Jkt 211001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 For the Nuclear Regulatory Commission. Nageswaran Kalyanam, Project Manager, Plant Licensing Branch IV, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. E7–5936 Filed 3–29–07; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Call for Nominations U.S. Nuclear Regulatory Commission. ACTION: Call for Nominations. AGENCY: SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising for nominations for the position of nuclear pharmacist on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominations are due on or before May 29, 2007. Nomination Process: Submit an electronic copy of resume or curriculum vitae to Ms. Ashley M. Tull, amt1@nrc.gov. Please ensure that resume or curriculum vitae includes the following information, if applicable: education, certification; professional association membership and committee membership activities; duties and responsibilities in current and previous clinical, research, and/or academic position(s), including traditional nuclear medicine, preparing and dispensing radiopharmaceuticals, and shipping and receiving radioactive material. DATES: FOR FURTHER INFORMATION CONTACT: Ashley M. Tull, U.S. Nuclear Regulatory Commission, Office of Federal and State Materials and Environmental Management Programs, Mail Stop T8– F3, Washington, DC 20555; (301) 415– 5294; amt1@nrc.gov. SUPPLEMENTARY INFORMATION: The ACMUI advises NRC on policy and technical issues that arise in the regulation of the medical use of byproduct material. Responsibilities include providing comments on changes to NRC rules, regulations, and guidance documents; evaluating certain nonroutine uses of byproduct material; providing technical assistance in licensing, inspection, and enforcement cases; and bringing key issues to the attention of NRC for appropriate action. ACMUI members possess the medical and technical skills needed to address evolving issues. The current membership is comprised of the following professionals: (a) Nuclear E:\FR\FM\30MRN1.SGM 30MRN1 Federal Register / Vol. 72, No. 61 / Friday, March 30, 2007 / Notices medicine physician; (b) nuclear cardiologist; (c) medical physicist in nuclear medicine unsealed byproduct material; (d) therapy medical physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) patients’ rights advocate; (i) Food and Drug Administration representative; (j) State representative; and (k) health care administrator. NRC is inviting nominations for the nuclear pharmacist appointment to the ACMUI. The term of the individual currently occupying this position will end September 2008. Committee members currently serve a four-year term and may be considered for reappointment to an additional term. Nominees must be U.S. citizens and be able to devote approximately 160 hours per year to Committee business. Members who are not Federal employees are compensated for their service. In addition, non-Federal members are reimbursed travel, secretarial and correspondence expenses. Full-time Federal employees are reimbursed travel expenses only. Security Background Check: The selected nominee will undergo a thorough security background check. Security paperwork may take the nominee several weeks to complete. Nominees will also be required to complete a financial disclosure statement to avoid conflicts of interest. Dated at Rockville, Maryland this 26th day of March 2007. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. E7–5918 Filed 3–29–07; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION cprice-sewell on PROD1PC66 with NOTICES Advisory Committee on Nuclear Waste Meeting on Planning and Procedures; Notice of Meeting The Advisory Committee on Nuclear Waste (ACNW) will hold a Planning and Procedures meeting on April 10, 2007, Room T–2B1, 11545 Rockville Pike, Rockville, Maryland. The entire meeting will be open to public attendance, with the exception of a portion that may be closed pursuant to 5 U.S.C. 552b(c)(2) and (6) to discuss organizational and personnel matters that relate solely to internal personnel rules and practices of ACNW, and information the release of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Aug<31>2005 15:49 Mar 29, 2007 Jkt 211001 The agenda for the subject meeting shall be as follows: Tuesday, April 10, 2007—8:30 a.m.–10 a.m. The Committee will discuss proposed ACNW activities and related matters. The purpose of this meeting is to gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the full Committee. Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official, Mr. Antonio F. Dias (Telephone: 301/415–6805) between 8:15 a.m. and 5 p.m. (ET) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Electronic recordings will be permitted only during those portions of the meeting that are open to the public. Further information regarding this meeting can be obtained by contacting the Designated Federal Official between 8:15 a.m. and 5 p.m. (ET). Persons planning to attend this meeting are urged to contact the above named individual at least two working days prior to the meeting to be advised of any potential changes in the agenda. Dated: March 22, 2007. Antonio F. Dias, Acting Branch Chief, ACNW. [FR Doc. E7–5919 Filed 3–29–07; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Interim Regulatory Guide: Issuance, Availability The U.S. Nuclear Regulatory Commission (NRC) has issued an interim revision to an existing guide in the agency’s Regulatory Guide Series. This series has been developed to describe and make available to the public such information as methods that are acceptable to the NRC staff for implementing specific parts of the agency’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. The revised guide, entitled ‘‘Quality Assurance for Radiological Monitoring Programs (Inception Through Normal Operations to License Termination)— Effluent Streams and the Environment,’’ is identified as Interim Revision 2 of Regulatory Guide 4.15. Like its predecessor, this interim revision describes a method that the NRC staff considers acceptable for use in PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 15173 designing and implementing programs to ensure the quality of the results of measurements of radioactive materials in the effluents from, and environment outside of, facilities that process, use, or store radioactive materials during all phases of the facility’s life cycle. Quality assurance (QA) is a fundamental expectation of Title 10, ‘‘Energy,’’ of the Code of Federal Regulations (10 CFR) for items and activities that are relied on to protect the health and safety of the public and the environment. This interim guide serves as a final regulatory guide for, and may be used by applicants and licensees of nuclear power reactors. It also presents draft NRC staff positions on a method for designing and implementing QA programs for use by non-nuclear power reactor applicants and licensees subject to the agency’s QA requirements. The NRC staff seeks public comments on this regulatory guide with respect to its application to such licensees. The NRC staff will issue this guide in final form after resolving any comments received during the public comment period. Interim Revision 2 of Regulatory Guide 4.15 specifically applies to facilities for which NRC regulations require routine monitoring of radioactive effluents to the environment, and particularly those facilities licensed under the following regulations: • 10 CFR Part 50, ‘‘Domestic Licensing of Production and Utilization Facilities’’ • 10 CFR Part 52, ‘‘Licenses, Certifications, and Approvals for Nuclear Power Plants’’ • 10 CFR Part 61, ‘‘Licensing Requirements for Land Disposal of Radioactive Waste’’ • 10 CFR Part 72, ‘‘Licensing Requirements for the Independent Storage of Spent Nuclear Fuel, HighLevel Radioactive Waste, and ReactorRelated Greater Than Class C Waste’’ • 10 CFR Part 76, ‘‘Certification of Gaseous Diffusion Plants’’ The guidance may also apply to other NRC-licensed facilities, for which the agency may impose specific license conditions for effluent or environmental monitoring, as deemed necessary to ensure the health and safety of the public and the environment, including those licensed under the following regulations: • 10 CFR Part 30, ‘‘Rules of General Applicability to Domestic Licensing of Byproduct Material’’ • 10 CFR Part 40, ‘‘Domestic Licensing of Source Material’’ • 10 CFR Part 70, ‘‘Domestic Licensing of Special Nuclear Material’’ E:\FR\FM\30MRN1.SGM 30MRN1

Agencies

[Federal Register Volume 72, Number 61 (Friday, March 30, 2007)]
[Notices]
[Pages 15172-15173]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-5918]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the position of nuclear pharmacist on the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI).

DATES: Nominations are due on or before May 29, 2007.
    Nomination Process: Submit an electronic copy of resume or 
curriculum vitae to Ms. Ashley M. Tull, amt1@nrc.gov. Please ensure 
that resume or curriculum vitae includes the following information, if 
applicable: education, certification; professional association 
membership and committee membership activities; duties and 
responsibilities in current and previous clinical, research, and/or 
academic position(s), including traditional nuclear medicine, preparing 
and dispensing radiopharmaceuticals, and shipping and receiving 
radioactive material.

FOR FURTHER INFORMATION CONTACT: Ashley M. Tull, U.S. Nuclear 
Regulatory Commission, Office of Federal and State Materials and 
Environmental Management Programs, Mail Stop T8-F3, Washington, DC 
20555; (301) 415-5294; amt1@nrc.gov.

SUPPLEMENTARY INFORMATION: The ACMUI advises NRC on policy and 
technical issues that arise in the regulation of the medical use of 
byproduct material. Responsibilities include providing comments on 
changes to NRC rules, regulations, and guidance documents; evaluating 
certain non-routine uses of byproduct material; providing technical 
assistance in licensing, inspection, and enforcement cases; and 
bringing key issues to the attention of NRC for appropriate action.
    ACMUI members possess the medical and technical skills needed to 
address evolving issues. The current membership is comprised of the 
following professionals: (a) Nuclear

[[Page 15173]]

medicine physician; (b) nuclear cardiologist; (c) medical physicist in 
nuclear medicine unsealed byproduct material; (d) therapy medical 
physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) 
two radiation oncologists; (h) patients' rights advocate; (i) Food and 
Drug Administration representative; (j) State representative; and (k) 
health care administrator.
    NRC is inviting nominations for the nuclear pharmacist appointment 
to the ACMUI. The term of the individual currently occupying this 
position will end September 2008. Committee members currently serve a 
four-year term and may be considered for reappointment to an additional 
term.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members who are not Federal 
employees are compensated for their service. In addition, non-Federal 
members are reimbursed travel, secretarial and correspondence expenses. 
Full-time Federal employees are reimbursed travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland this 26th day of March 2007.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E7-5918 Filed 3-29-07; 8:45 am]
BILLING CODE 7590-01-P